Market revenue in 2023 | USD 10,431.2 million |
Market revenue in 2030 | USD 2,188.9 million |
Growth rate | -20% (CAGR from 2023 to 2030) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data covered | 2020 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents & Kits, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Hologic Inc, Roche, PerkinElmer, Veredus Laboratories, QuidelOrtho Corp, Quest Diagnostics Inc, Luminex, Labcorp Holdings Inc, Abbott Laboratories, 1Drop Diagnostics, ADT Inc, Mylab Discovery Solutions, Neuberg Diagnostics, Aldatu Biosciences, altona Diagnostics GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 67.05% in 2023. Horizon Databook has segmented the North America covid-19 diagnostics market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2020 to 2030.
North America's COVID-19 diagnostic market is estimated to grow at a moderate rate over the forecast period. The significant rise of COVID-19 cases and local presence of major players involved in research and manufacture of diagnostic tests, utilizing various technologies, can be attributed to the market's growth.
As reported by World meter, as of June 2021, the number of COVID-19 cases in North America had reached 40,032,365, indicating the increased use of COVID-19 diagnostic kits in the region. Due to the pandemic, governing bodies such as Health Canada and the U.S. FDA are allowing Emergency Use Authorizations (EUAs) for COVID-19 test kits, to increase testing.
These factors are projected to drive regional market growth. Furthermore, owing to the surge in the number of COVID-19 cases following the ease of lockdown, the market for COVID-19 diagnostic kits is predicted to significantly grow during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America covid-19 diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America covid-19 diagnostics market from 2020 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account